ArticleClinical drug investigation2026

Safety, Tolerability, and Pharmacokinetics of Subcutaneous Extended-Release Injectable Olanzapine in Patients with Schizophrenia and Schizoaffective Disorder.

Irina Cherniakov et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.